Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Merck and Company    MRK

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Latest Tweets
01:04aDow Jones Analysis Video - $DJIA $DIA $SDOW $XOM $GE $GS $MRK $PFE $BMY $VZ .. 
12:17a$MRK - Merck KGaA #MRK Receives €109.43 Average Price Target from Br.. 
10/16  
10/16Long 3k shares of $KALV ($27 price target today + partnership with Merck) 
10/16$TSPT AGLE: Aeglea Announces Collaboration with Merck for SCLC Study From our.. 
10/16Merck targets high-risk military veterans for hepatitis C lessons: Fierce Pha.. 
10/16Merck & Company, Inc. $MRK Given Outperform Rating at BMO Capital Markets.. 
10/16  
10/16BRIEF-Aeglea Biotherapeutics announces clinical collaboration with Merck  
10/16$MRK targets high-risk military veterans for hepatitis C lessons  
10/16$AGLE: Aeglea BioTherapeutics enters into clinical collaboration agreement wi..
1
10/16Merck and J&J are smart to back away from the hepatitis C drug market
1
10/16Aeglea BioTherapeutics Announces Clinical Collaboration with Merck to Evaluat.. 
10/16Merck & Company, Inc. $MRK Holdings Raised by Sei Investments Co.  
10/16$MRK "VDRM VIABECLINE/TETRASTEM USES" on ADFN InvestorsHub message boards:  
10/15Papp L Roy & Associates Has $709,000 Stake in Merck & Company, Inc. $.. 
10/15Brave Asset Management Inc. Has $1.54 Million Stake in Merck & Company, I.. 
10/14Merck & Company, Inc. $MRK Rating Reiterated by BMO Capital Markets  
10/14Web Stock buzz: $MSFT $WCG $GOOG $MRK $PNC (10:41 am) #stocks #finance #stock.. 
10/14SWING TRADE ALERT: $MRK technical alerts: New Downtrend, Stochastic Reached O.. 
10/14Merck & Company, Inc. $MRK Position Lifted by Ingalls & Snyder LLC  
10/13Ebola vaccines from GlaxoSmithKline, Merck elicit yearlong response, study fi..
1
10/13Glaxo shingles vaccine OK'd in Canada  
10/13Merck KGaA, Darmstadt, Germany & Pfizer’s immunotherapy receives FDA Orph..
2
10/13Robert Davis hired as aide to state lawmaker
2
10/13Ebola vaccines from $GSK, $MRK elicit yearlong response
3
10/13Pfizer: Could a Big Merger Move the Needle?  
10/13$KALV is a low float stock (can run fast). Don’t forget $MRK Merck Acquired 9.. 
10/13And what about Merck?
1
10/13In case you were wondering about that CETP inhibitor $AMGN bought with Dezima..
1
10/13Merck & Company, Inc. $MRK Position Held by NJ State Employees Deferred C.. 
10/13State of New Jersey Common Pension Fund D Sells 130,000 Shares of Merck &.. 
10/13Dow Jones Analysis Video - $DJIA $DIA $SDOW $XOM $GE $GS $MRK $PFE $BMY $VZ .. 
10/13Top - Positive PhIII can’t salvage Merck’s anacetrapib, now relegated to the ..
1
10/12Merck scraps disappointing experimental cholesterol drug  
10/12CETP inhibitor class still seeking salvation after $MRK drops anacetrapib pro..
1
10/12
1
10/12Merck Makes $3 Million Charitable Donation to Support Swim Across America: KE.. 
10/12Merck Makes $3 Million Charitable Donation to Support Swim Across America  
10/12  
10/12With Merck not taking anacetrapib forward, will any of the folks specializing.. 
10/12Health care news releases may not tell the whole story: Merck edition.
4
10/12Merck scraps disappointing experimental cholesterol drug  
10/12Global Allergy Immunotherapy Market 2017-2021 Featuring ALK-Abello, Allergy T.. 
10/12Global Allergy Immunotherapy Market 2017-2021 Featuring ALK-Abello, Allergy T.. 
10/12Merck Abandons Plans to Seek #FDA Approval of Cholesterol Drug |  
10/12Merck & Company's outperform rating reiterated at BMO Capital Markets. $7.. 
10/12Web Stock buzz: $ACRX $GE $MRK $JWN $BOH (10:33 am) #stocks #finance #stockma.. 
10/12Merck scraps disappointing experimental cholesterol drug  
10/12SWING TRADE ALERT: Recent $MRK technical alerts: Fell Below 50 DMA plus 4 mor.. 
More tweets
Qtime:363
Financials ($)
Sales 2017 40 274 M
EBIT 2017 13 680 M
Net income 2017 5 795 M
Debt 2017 8 102 M
Yield 2017 2,98%
P/E ratio 2017 31,63
P/E ratio 2018 18,86
EV / Sales 2017 4,49x
EV / Sales 2018 4,42x
Capitalization 173 B
Chart MERCK AND COMPANY
Duration : Period :
Merck and Company Technical Analysis Chart | MRK | US58933Y1055 | 4-Traders
Technical analysis trends MERCK AND COMPANY
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 69,6 $
Spread / Average Target 9,8%
EPS Revisions
Managers
NameTitle
Kenneth C. Frazier Chairman, President & Chief Executive Officer
Robert M. Davis CFO & Executive Vice President-Global Services
Clark Golestani Chief Information Officer & Executive VP
Thomas Henry Glocer Independent Director
Rochelle B. Lazarus Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MERCK AND COMPANY7.68%172 887
JOHNSON & JOHNSON18.42%366 178
NOVARTIS13.23%225 160
ROCHE HOLDING LTD.5.20%216 764
PFIZER11.88%216 409
AMGEN25.17%133 538